This is an application for a competitive continuation of a program project that focuses on the role of Calcium Regulation in Brain Aging and Alzheimer's Disease and on basic processes that underlie neuronal vulnerability. During the prior period, investigators in the program project were able to elucidate a number of key changes in calcium regulation in brain cells of aging animals and in models of neurodegeneration/Alzheimer's disease. New evidence was also obtained that such changes in calcium regulation may be directly relevant to neurodegenerative processes. In addition, program project investigators uncovered new leads and performed tests of several hypotheses on the possible causal bases of age-related calcium dysregulation. During the next period, it is proposed to pursue a comprehensive approach to the study of calcium regulation in brain aging and Alzheimer's disease, using advanced technologies for calcium imaging, electrophysiology and molecular biology. The Program Project (PGP) will consist of five projects and one administrative core. The projects will test several hypotheses of the initial causes of calcium dysregulation including the role of steroid hormones (which have specific target sites in brain cells), altered gene expression of function, and brain energy metabolism. Specific neuronal sites of calcium dysregulation that will be examined include membrane ion channels, endoplasmic reticulum, mitochondria, the cytoskeleton and intracellular signaling pathways. In addition, related studies will be conducted directly on autopsy brain tissues from AD and control subjects. The PGP brings together investigators with a natural interest in the mechanisms of calcium regulation and neurotoxicity, and skills in advanced technologies. These investigators will share overlapping models and collaborate extensively on related subjects, thereby ensuring strong cross-fertilization and multi-disciplinary approaches to the key questions under investigation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010836-10
Application #
6624582
Study Section
Special Emphasis Panel (ZAG1-PCR-5 (M1))
Program Officer
Snyder, Stephen D
Project Start
1992-08-20
Project End
2004-08-31
Budget Start
2003-01-01
Budget End
2004-08-31
Support Year
10
Fiscal Year
2003
Total Cost
$1,141,428
Indirect Cost
Name
University of Kentucky
Department
Pharmacology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Cenini, Giovanna; Fiorini, Ada; Sultana, Rukhsana et al. (2014) An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach. Free Radic Biol Med 76:89-95
Barone, Eugenio; Di Domenico, Fabio; Mancuso, Cesare et al. (2014) The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis 62:144-59
Förster, Sarah; Welleford, Andrew S; Triplett, Judy C et al. (2014) Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain. Biochim Biophys Acta 1842:1333-9
Swomley, Aaron M; Förster, Sarah; Keeney, Jierel T et al. (2014) Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta 1842:1248-57
Latimer, Caitlin S; Brewer, Lawrence D; Searcy, James L et al. (2014) Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A 111:E4359-66
Butterfield, D Allan; Di Domenico, Fabio; Barone, Eugenio (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 1842:1693-706
Perluigi, Marzia; Di Domenico, Fabio; Buttterfield, D Allan (2014) Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics. Proteomics Clin Appl 8:73-85
Farr, Susan A; Ripley, Jessica L; Sultana, Rukhsana et al. (2014) Antisense oligonucleotide against GSK-3? in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 67:387-95

Showing the most recent 10 out of 356 publications